FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary O'REILLY

Research Profile

Disorders

Retinitis Pigmentosa

Procedures

Chemicals & Drugs

Living Beings

Physiology

Devices

Gene Transfer Techniques

Co-author Network

Publications

TOP 3
Naomi Chadderton; Carsten Ehrhardt; OL Gobbo; Peter Humphries; Paul F Kenna; Sophia Millington-Ward; Mary O'REILLY; Nora Overlack; Arpad Palfi; Uwe Wolfrum; Matthew Campbell; Matthew Carrigan; G Jane Farrar
Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.
Juan F Marquez Ruiz; Mary O'REILLY; Henry J Windle; Kinga Kedziora; Dermot P Kelleher; Brian Keogh; Jacqueline Maguire; John F Gilmer
Azo-reductase activated budesodine prodrugs for colon targeting.
Sophia Millington-Ward; Naomi Chadderton; Mary O'REILLY; Arpad Palfi; Tobias Goldmann; Claire Kilty; Marian Humphries; Uwe Wolfrum; Jean Bennett; Peter Humphries; Paul F Kenna; G Jane Farrar
Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary O'REILLY (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Naomi Chadderton; Carsten Ehrhardt; OL Gobbo; Peter Humphries; Paul F Kenna; Sophia Millington-Ward; Mary O'REILLY; Nora Overlack; Arpad Palfi; Uwe Wolfrum; Matthew Campbell; Matthew Carrigan; G Jane Farrar
Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.
European journal of human genetics : EJHG 2013;21(1):62-8.
2012: Juan F Marquez Ruiz; Mary O'REILLY; Henry J Windle; Kinga Kedziora; Dermot P Kelleher; Brian Keogh; Jacqueline Maguire; John F Gilmer
Azo-reductase activated budesodine prodrugs for colon targeting.
Bioorganic & medicinal chemistry letters 2012;22(24):7573-7.
2011: Sophia Millington-Ward; Naomi Chadderton; Mary O'REILLY; Arpad Palfi; Tobias Goldmann; Claire Kilty; Marian Humphries; Uwe Wolfrum; Jean Bennett; Peter Humphries; Paul F Kenna; G Jane Farrar
Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(4):642-9.
2010: G Jane Farrar; Arpad Palfi; Mary O'REILLY
Gene therapeutic approaches for dominant retinopathies.
Current gene therapy 2010;10(5):381-8.
2010: Arpad Palfi; Sophia Millington-Ward; Naomi Chadderton; Mary O'REILLY; Tobias Goldmann; Marian Humphries; Tiansen Li; Uwe Wolfrum; Peter Humphries; Paul F Kenna; G Jane Farrar
Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene.
Human gene therapy 2010;21(3):311-23.
2009: Naomi Chadderton; Sophia Millington-Ward; Arpad Palfi; Mary O'REILLY; Gearóid Tuohy; Marian Humphries; Tiansen Li; Peter Humphries; Paul F Kenna; G Jane Farrar
Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(4):593-9.
2008: Mary O'REILLY; Sophia Millington-Ward; Arpad Palfi; Naomi Chadderton; Thérèse Cronin; Niamh McNally; Marian Humphries; Peter Humphries; Paul F Kenna; G Jane Farrar
A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
Vision research 2008;48(3):386-91.
2007: Mary O'REILLY; Arpad Palfi; Naomi Chadderton; Sophia Millington-Ward; Marius Ader; Thérèse Cronin; Thérèse Tuohy; Alberto Auricchio; Markus Hildinger; Amanda Tivnan; Niamh McNally; Marian Humphries; Anna-Sophia Kiang; Peter Humphries; Paul F Kenna; G Jane Farrar
RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
American journal of human genetics 2007;81(1):127-35.
2007: Danny Allen; Paul F Kenna; Arpad Palfi; Helena P McMahon; Sophia Millington-Ward; Mary O'REILLY; Peter Humphries; G Jane Farrar
Development of strategies for conditional RNA interference.
The journal of gene medicine 2007;9(4):287-98.
2006: Arpad Palfi; Marius Ader; Anna-Sophia Kiang; Sophia Millington-Ward; Gerry Clark; Mary O'REILLY; Helena P McMahon; Paul F Kenna; Peter Humphries; G Jane Farrar
RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture.
Human mutation 2006;27(3):260-8.
2005: Anna-Sophia Kiang; Arpad Palfi; Marius Ader; Paul F Kenna; Sophia Millington-Ward; Gerry Clark; Avril Kennan; Mary O'REILLY; Lawrence C T Tam; Aileen Aherne; Niamh McNally; Peter Humphries; G Jane Farrar
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(3):555-61.
2000: Brian O'Neill; Sophia Millington-Ward; Mary O'REILLY; Gearóid Tuohy; Anna-Sophia Kiang; Paul F Kenna; Peter Humphries; G Jane Farrar
Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.
Investigative ophthalmology & visual science 2000;41(10):2863-9.